GemVax Raises 52.1 Billion KRW Through Capital Increase and Convertible Bonds
On December 24, GemVax, a KOSDAQ-listed company, announced that it has decided to raise approximately 17 billion KRW in operating funds, including research and development expenses, through a third-party allotment capital increase. The recipients are Gem&Company, the largest shareholder, and Kim Kiho, CEO of GemVax.
On the same day, GemVax also announced that it would raise 35.1 billion KRW in operating funds, including research and development expenses, through the issuance of convertible bonds (CB). The maturity date for the bonds is January 23, 2029.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- Fed Turns Hawkish in a Month, Hints at Possibility of "Additional Policy Firming"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
As a result, GemVax will have raised a total of 52.1 billion KRW in funds.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
